Immuno-oncology: AACR Partners with FDA to Accelerate the Pace of Progress
The potential for developing new immunotherapies and expanding the use of existing ones will be the focus of the...
Tag: FDA
The potential for developing new immunotherapies and expanding the use of existing ones will be the focus of the...
On June 1, the U.S. Food and Drug Administration (FDA) approved a liquid biopsy test, a companion diagnostic test...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of cancer types for which immunotherapeutics known...
Late last week, the U.S. Food and Drug Administration (FDA) added another antiangiogenic therapeutic to the armamentarium for oncologists...
The U.S. Food and Drug Administration (FDA) recently approved the use of molecularly targeted therapeutic afatinib (Gilotrif) for treating...
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the antiangiogenic...
Earlier this month, the U.S. Food and Drug Administration (FDA) approved a new colorectal cancer screening test, the ‘System,...
Last week, the U.S. Food and Drug Administration (FDA) added another therapeutic to the armamentarium for hematologist-oncologists when it...
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of crizotinib (Xalkori)...
At the end of last week, the U.S. Food and Drug Administration (FDA) approved the immunotherapeutic obinutuzumab (Gazyva) for...